Finneran, Phoebe
Toribio, Mabel P.
Natarajan, Pradeep
Honigberg, Michael C. http://orcid.org/0000-0001-8630-5021
Article History
Received: 25 August 2023
Accepted: 17 November 2023
First Online: 4 December 2023
Declarations:
:
: Dr. Natarajan reports grant support from Amgen, Apple, AstraZeneca, Boston Scientific, and Novartis, spousal employment and equity at Vertex, consulting income from Apple, AstraZeneca, Novartis, Genentech / Roche, Blackstone Life Sciences, Foresite Labs, and TenSixteen Bio, and is a scientific advisor board member and shareholder of TenSixteen Bio and geneXwell, all unrelated to this work. Dr. Honigberg reports consulting fees from CRISPR Therapeutics, advisory board service for Miga Health, and grant support from Genentech, all unrelated to this work.